Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Cervical Cancer Screening 1Breast Neoplasms 1

Interventions

Specimen Handling 655pembrolizumab 605Magnetic Resonance Spectroscopy 562Carboplatin 445Cisplatin 396Cyclophosphamide 394Biopsy 378Nivolumab 323Paclitaxel 320Gemcitabine 313Radiotherapy 293Bevacizumab 248Dexamethasone 221fludarabine 212Docetaxel 201durvalumab 193atezolizumab 186Oxaliplatin 186venetoclax 182Fluorouracil 175Rituximab 173Pemetrexed 172Capecitabine 170Radiation 166Doxorubicin 166Radiosurgery 158Ipilimumab 145Etoposide 142Leucovorin 140Lenalidomide 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Coal Tar × 90 days × Clear all
NCT07538050 2026-05-28

SCALE AIM 2

The Cleveland Clinic

Phase NA Recruiting
1,000 enrolled
Gynecologic

Cervical Cancer Screening

NCT05012813 2026-03-09

Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer

OHSU Knight Cancer Institute

Phase NA Completed
28 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡